Our finding that TLR2 ligands directly promote upregulation of PDL1 in HNSCC models supports future inquiry into the impact of oral microbiome composition on response to immunotherapy and whether this could be influenced by tumor-intrinsic aberrant expression or activity of TLRs. The gene discussed is TLR2; the disease is neoplasm.